Page J D, Chaney S G, Hall I H, Lee K H, Holbrook D J
Department of Biochemistry and Nutrition, School of Medicine, University of North Carolina, Chapel Hill 27514.
Biochim Biophys Acta. 1987 Nov 6;926(2):186-94. doi: 10.1016/0304-4165(87)90236-4.
Inosine monophosphate (IMP) dehydrogenase had previously been determined to be a likely target enzyme for the sesquiterpene lactones, a class of potential anti-neoplastic drugs. IMP dehydrogenase was purified approx. 770-fold from the P-388 lymphocytic leukemia tumor cell line. The Km values for the substrates, IMP and NAD, were determined to be 12 microM and 25 microM, respectively. Xanthine monophosphate (XMP) was shown to be a competitive inhibitor with a Ki of 67 microM. Mycophenolic acid gave mixed-type inhibition with a Ki of 8 nM for the noncompetitive component and a Ki of 2 nM for the competitive component. Dissociation constants (Kd) and rate constants for inhibition of IMP dehydrogenase by nine different sesquiterpene lactones were determined. The highest Kd was seen with 2,3-dihydrohelenalin while the lowest Kd was observed with bis-helenalinyl malonate. Binding of the drugs by IMP dehydrogenase increased as the size of the drug increased. Also, changes in structure at position 6 had a relatively large effect on the Kd. There was no correlation with hydrophobicity, as determined by octanol/water partition. The first-order rate constants for the reaction of the sesquiterpene lactones with IMP dehydrogenase (k1) and the second-order rate constants for the reaction of the sesquiterpene lactones with glutathione (k2) were also determined. The rate constants for most of the sesquiterpene lactones with the alpha-methylene-gamma-lactone moiety were similar and were approximately twice as great as the rate constants for those sesquiterpene lactones with only the alpha, beta-unsaturated cyclopentenone ring. Microlenin had approximately 5-times the reactivity of the other sesquiterpene lactones towards IMP dehydrogenase, but had approximately the same reactivity towards glutathione, suggesting that it was bound to the enzyme in a way which facilitated its reaction with one or more essential sulfhydryls. The same procedure was used for a series of N-substituted maleimide compounds with the N-substituent ranging in size from a methyl group to a benzyl group. The binding of the maleimide compounds was generally tighter than for the sesquiterpene lactones and there was an increase in binding with size.
肌苷一磷酸(IMP)脱氢酶先前已被确定为倍半萜内酯(一类潜在的抗肿瘤药物)可能的靶标酶。从P - 388淋巴细胞白血病肿瘤细胞系中纯化出了约770倍的IMP脱氢酶。底物IMP和NAD的米氏常数(Km值)分别测定为12微摩尔和25微摩尔。黄嘌呤一磷酸(XMP)被证明是一种竞争性抑制剂,其抑制常数(Ki)为67微摩尔。霉酚酸产生混合型抑制,其非竞争性成分的Ki为8纳摩尔,竞争性成分的Ki为2纳摩尔。测定了9种不同倍半萜内酯对IMP脱氢酶抑制作用的解离常数(Kd)和速率常数。2,3 - 二氢海仑内酯的Kd最高,而双海仑内酯基丙二酸的Kd最低。IMP脱氢酶与药物的结合随着药物尺寸的增加而增加。此外,6位结构的变化对Kd有相对较大的影响。通过正辛醇/水分配测定,与疏水性没有相关性。还测定了倍半萜内酯与IMP脱氢酶反应的一级速率常数(k1)以及倍半萜内酯与谷胱甘肽反应的二级速率常数(k2)。大多数具有α - 亚甲基 - γ - 内酯部分的倍半萜内酯的速率常数相似,大约是那些仅具有α,β - 不饱和环戊烯酮环的倍半萜内酯速率常数的两倍。微菌素对IMP脱氢酶的反应活性约为其他倍半萜内酯的5倍,但对谷胱甘肽的反应活性大致相同,这表明它以一种促进其与一个或多个必需巯基反应的方式与酶结合。对一系列N - 取代马来酰亚胺化合物采用了相同的程序,其中N - 取代基的大小从甲基到苄基不等。马来酰亚胺化合物的结合通常比倍半萜内酯更紧密,并且结合随着尺寸的增加而增加。